Dow Down 0.62% Nasdaq Down 1.14%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
10.44 Down 0.49(4.48%) 4:00PM EDT
|After Hours : 10.14 Down 0.30 (2.87%) 4:38PM EDT
Prev Close:10.93
Open:10.88
Bid:9.64 x 2000
Ask:10.40 x 100
1y Target Est:17.73
Beta:3.29
Next Earnings Date: 6-Nov-14BCRX Earnings announcement
Day's Range:10.17 - 10.90
52wk Range:4.55 - 14.62
Volume:1,421,943
Avg Vol (3m):1,255,760
Market Cap:749.13M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXDown 4.48%749.13M
GSKDown 0.13%113.66B
RHHBYUp 0.07%255.90B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):43.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.83
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-1.83

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback